Td Asset Management Inc Kinnate Biopharma Inc. Transaction History

Td Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$17.81 - $24.87 $666,218 - $930,312	-37,407 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$22.19 - $31.55 $161,987 - $230,315	-7,300 Reduced 16.33%	37,407 $807,000
Q1 2021 May 14, 2021	BUY	$26.99 - $40.0 $173,302 - $256,840	6,421 Added 16.77%	44,707 $1.39 Million
Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $1.39 Million - $1.73 Million	38,286 New	38,286 $1.52 Million

32.9M

94.7K

802K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.